• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人百白破加强疫苗接种:意大利对当前建议的真实世界依从性以及两种替代策略的评估。

Tdap Booster Vaccination for Adults: Real-World Adherence to Current Recommendations in Italy and Evaluation of Two Alternative Strategies.

机构信息

Department Biomedical Sciences for Health, Postgraduate School in Public Health, University of Milan, 20136 Milan, Italy.

Quality Unit Fondazione IRCCS Ca' Granda OMP, 20122 Milan, Italy.

出版信息

Int J Environ Res Public Health. 2022 Mar 29;19(7):4066. doi: 10.3390/ijerph19074066.

DOI:10.3390/ijerph19074066
PMID:35409744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8998621/
Abstract

Background: While the effectiveness of tetanus-diphtheria-pertussis childhood immunization programs is unquestionable, the actual need for a periodic boosting vaccination in adults is controversial. In Italy, the Ministry of Health recommends a Tdap booster vaccination every 10 years. The aim of this study is to assess the real-world adherence of Italian regional healthcare services to national recommendations and to evaluate two alternative strategies. Methods: Annual Tdap vaccine requirements by the 21 Italian regions were retrieved from related tender announcements, and regional and national vaccination coverage rates (VCRs) were estimated for three scenarios, namely the currently recommended 10-year booster vaccination, a single booster shot at age 50 and at age 65. Results: In Scenario 1, no region reached a VCR > 30%, and the national VCR was 10.6%; in Scenario 2, five regions achieved the optimal vaccination coverage of ≥95%, but the vast majority continued to have inadequate VCRs, with a national VCR of 54.4%; in Scenario 3, five regions reached VCRs exceeding 100%, with VCRs from other regions significantly improving and a national VCR of 74.8%. Conclusions: A substantial lack of adherence by Italian regional healthcare services to current national recommendations on tetanus-diphtheria-pertussis adult vaccination was shown. Scenario 3 is the most feasible, i.e., a single booster shot at age 65, possibly administrable along with other already-recommended, age-specific vaccines.

摘要

背景

虽然破伤风白喉无细胞百日咳儿童免疫计划的有效性是毋庸置疑的,但成年人定期加强接种疫苗的实际需求仍存在争议。在意大利,卫生部建议每 10 年进行一次 Tdap 加强疫苗接种。本研究旨在评估意大利各地区卫生保健服务机构对国家建议的实际遵循情况,并评估两种替代策略。方法:从相关招标公告中获取了意大利 21 个地区每年 Tdap 疫苗的需求,并根据三种情况估计了地区和国家疫苗接种覆盖率(VCR),即目前建议的 10 年加强疫苗接种、50 岁和 65 岁时的单次加强接种。结果:在方案 1 中,没有一个地区的 VCR 超过 30%,全国 VCR 为 10.6%;在方案 2 中,有五个地区达到了最佳的 95%以上的接种覆盖率,但绝大多数地区的 VCR 仍然不足,全国 VCR 为 54.4%;在方案 3 中,有五个地区的 VCR 超过 100%,其他地区的 VCR 显著提高,全国 VCR 为 74.8%。结论:意大利各地区卫生保健服务机构对当前国家破伤风白喉无细胞百日咳成人疫苗接种建议的遵循程度明显不足。方案 3 是最可行的,即 65 岁时进行单次加强接种,可能与其他已建议的、年龄特定的疫苗同时进行。

相似文献

1
Tdap Booster Vaccination for Adults: Real-World Adherence to Current Recommendations in Italy and Evaluation of Two Alternative Strategies.成人百白破加强疫苗接种:意大利对当前建议的真实世界依从性以及两种替代策略的评估。
Int J Environ Res Public Health. 2022 Mar 29;19(7):4066. doi: 10.3390/ijerph19074066.
2
Vaccination coverage rates for Diphtheria, Tetanus, Poliomyelitis and Pertussis booster vaccination in France between 2013 and 2017: Learnings from an analysis of National Health System Real-World Data.2013 年至 2017 年期间法国白喉、破伤风、脊髓灰质炎和百日咳加强疫苗接种的疫苗接种覆盖率:基于国家卫生系统真实世界数据的分析结果。
Vaccine. 2021 Jan 15;39(3):505-511. doi: 10.1016/j.vaccine.2020.12.021. Epub 2020 Dec 21.
3
Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.成人接种含低剂量抗原的白喉-破伤风-无细胞百日咳疫苗(Tdap)初免加强后 9 年,抗体持久性、安全性和免疫原性。
Vaccine. 2018 Oct 8;36(42):6325-6333. doi: 10.1016/j.vaccine.2018.08.051. Epub 2018 Sep 7.
4
Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.吸附无细胞百白破灭活、全细胞百日咳和破伤风联合疫苗(Boostrix®):作为单剂加强免疫的特性和用途介绍。
Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000.
5
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).预防青少年破伤风、白喉和百日咳:破伤风类毒素、白喉类毒素含量降低的无细胞百日咳疫苗的使用——免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.
6
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.一项关于破伤风、白喉和无细胞百日咳(Tdap)疫苗与破伤风和白喉(Td)疫苗作为健康成年人加强针时的安全性和免疫原性的随机、双盲、非劣效性临床试验比较。
Vaccine. 2012 Aug 10;30(37):5464-71. doi: 10.1016/j.vaccine.2012.06.073. Epub 2012 Jul 6.
7
Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.青少年首针加强免疫 10 年后接种含低含量抗原白喉破伤风联合无细胞百日咳疫苗的二价加强免疫的免疫原性和安全性:一项开放、III 期、非随机、多中心研究。
Hum Vaccin Immunother. 2018;14(8):1977-1986. doi: 10.1080/21645515.2018.1460292. Epub 2018 May 10.
8
Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.母亲接种白喉-破伤风-无细胞百日咳疫苗对幼儿百日咳加强免疫反应的影响:一项随机试验的随访。
Vaccine. 2021 Mar 12;39(11):1598-1608. doi: 10.1016/j.vaccine.2021.02.001. Epub 2021 Feb 19.
9
Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.预防成人破伤风、白喉和百日咳:免疫实践咨询委员会(ACIP)关于使用破伤风类毒素、吸附白喉类毒素和无细胞百日咳疫苗的建议,以及在医疗感染控制实践咨询委员会(HICPAC)支持下,ACIP关于医护人员使用破伤风类毒素、低剂量白喉类毒素和无细胞百日咳疫苗(Tdap)的建议。
MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37.
10
Spotlight on Tdap₅ vaccine (Covaxis®) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (aged ≥4 years), adolescents, and adults.聚焦 Tdap₅ 疫苗(Covaxis®)作为预防破伤风、白喉和百日咳的单一加强免疫接种:用于儿童(≥4 岁)、青少年和成人。
Paediatr Drugs. 2011 Apr 1;13(2):133-5. doi: 10.2165/11206990-000000000-00000.

引用本文的文献

1
Pertussis Vaccination for Adults: An Updated Guide for Clinicians.成人百日咳疫苗接种:临床医生最新指南
Vaccines (Basel). 2025 Jan 11;13(1):60. doi: 10.3390/vaccines13010060.
2
Pertussis Notification Rate and Tdpa Vaccine/Booster Coverage in Adults: An Opportunity for an Epidemiological Observatory in Primary Care.成人百日咳报告率及破伤风、白喉、无细胞百日咳疫苗/加强剂接种覆盖率:基层医疗中建立流行病学监测点的契机
Infect Dis Rep. 2024 Sep 2;16(5):870-879. doi: 10.3390/idr16050068.
3
Factors behind Antibiotic Therapy: A Survey of Primary Care Pediatricians in Lombardy.抗生素治疗的背后因素:伦巴第初级保健儿科医生调查。
Int J Environ Res Public Health. 2024 Aug 18;21(8):1091. doi: 10.3390/ijerph21081091.
4
Vaccination Open Day: A Cross-Sectional Study on the 2023 Experience in Lombardy Region, Italy.接种开放日:意大利伦巴第大区 2023 年的横断面研究。
Int J Environ Res Public Health. 2024 May 27;21(6):685. doi: 10.3390/ijerph21060685.

本文引用的文献

1
Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries.18 个欧洲国家中年人群百日咳流行和对白喉保护力差的情况。
Nat Commun. 2021 May 17;12(1):2871. doi: 10.1038/s41467-021-23114-y.
2
Vaccination of Adults and the Older Population against Tetanus, Diphtheria, Pertussis, and Tick-Borne Encephalitis: The Importance of Booster Vaccinations throughout Life.成人及老年人群破伤风、白喉、百日咳和蜱传脑炎疫苗接种:终生加强接种的重要性
Interdiscip Top Gerontol Geriatr. 2020;43:146-157. doi: 10.1159/000504489. Epub 2020 Apr 9.
3
Tetanus and Diphtheria Boosters.破伤风和白喉加强针
Clin Infect Dis. 2020 Dec 15;71(12):3266-3267. doi: 10.1093/cid/ciaa359.
4
The changing epidemiology of diphtheria in the United Kingdom, 2009 to 2017.2009 年至 2017 年期间英国白喉流行病学变化。
Euro Surveill. 2020 Mar;25(11). doi: 10.2807/1560-7917.ES.2020.25.11.1900462.
5
Incidence of Tetanus and Diphtheria in Relation to Adult Vaccination Schedules.破伤风和白喉的发病率与成人免疫接种计划的关系。
Clin Infect Dis. 2021 Jan 27;72(2):285-292. doi: 10.1093/cid/ciaa017.
6
The immune status against tetanus and diphtheria in healthcare workers in Catalonia.加泰罗尼亚医护人员破伤风和白喉的免疫状况。
Vaccine. 2020 Mar 10;38(12):2646-2650. doi: 10.1016/j.vaccine.2020.01.076. Epub 2020 Feb 13.
7
Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review.孕期接种无细胞百白破疫苗的安全性和有效性:系统评价。
BMC Infect Dis. 2020 Feb 13;20(1):136. doi: 10.1186/s12879-020-4824-3.
8
Duration of Immunity and Effectiveness of Diphtheria-Tetanus-Acellular Pertussis Vaccines in Children.儿童白喉-破伤风-无细胞百日咳疫苗的免疫持续时间和有效性。
JAMA Pediatr. 2019 Jun 1;173(6):588-594. doi: 10.1001/jamapediatrics.2019.0711.
9
Tetanus-diphtheria vaccination in adults: the long-term persistence of antibodies is not dependent on polyclonal B-cell activation and the defective response to diphtheria toxoid re-vaccination is associated to HLADRB1∗01.成人破伤风白喉联合疫苗接种:抗体的长期持续存在不依赖于多克隆 B 细胞的激活,对白喉类毒素再次接种的反应缺陷与 HLADRB1∗01 相关。
Vaccine. 2018 Oct 29;36(45):6718-6725. doi: 10.1016/j.vaccine.2018.09.041. Epub 2018 Sep 27.
10
Protection against Tetanus and Diphtheria in Europe: The impact of age, gender and country of origin based on data from the MARK-AGE Study.欧洲破伤风和白喉的预防:基于 MARK-AGE 研究数据的年龄、性别和原籍国的影响。
Exp Gerontol. 2018 May;105:109-112. doi: 10.1016/j.exger.2017.08.037. Epub 2017 Oct 7.